https://careers.astrazeneca.com/job/waltham/machine-learning-to-predict-cv-and-renal-outcomes/7684/16098217

Applications are invited for the post-doctoral fellowship opportunity described 
below in the Astrazeneca Clinical Pharmacology & Quantitative Pharmacology 
department

Machine Learning to Predict CV and Renal Outcomes

Locations: Waltham, Massachusetts, United States or Gaithersburg, Maryland, 
United States
Job ID R-080721
Date posted 07/30/2020
APPLY<https://astrazeneca.wd3.myworkdayjobs.com/Emerging-Talent/job/US---Gaithersburg---MD/Machine-Learning-to-Predict-CV-and-Renal-Outcomes_R-080721-1>

Do you want your work to truly make a difference?

About the Postdoc Program:
We're currently looking for talented scientists to join our innovative 
academic-style Postdoc. From our center in Gaithersburg, MD or Waltham, MA, 
you'll be in a global pharmaceutical environment, contributing to live projects 
right from the start. You'll take part in a comprehensive training program, 
including a focus on drug discovery and development, given access to our 
existing Postdoctoral research, and be encouraged to pursue your own 
independent research working with cutting edge Machine Learning/Data Science 
tools.

What's more, you'll have the support of a leading academic advisor, who'll 
provide you with the guidance and knowledge you need to develop your career. 
This is an exciting area that hasn't been explored to its full potential, 
making this an opportunity to make a real difference to the future of medical 
science.

About the Opportunity:
We will use artificial intelligence tools and computational modelling to 
predict individual long-term risk of major CV events (MACE) and renal disease 
based on patient characteristics and short-term biomarker changes in a very 
large combined database of AstraZeneca's cardiovascular outcomes trials 
(patient-level data for ~180 000 individuals). This will facilitate treatment 
selection for patients with diabetes and cardiovascular disease by identifying 
characteristics that predict therapeutic response or non-response to different 
drug classes, inform patient selection and outcome definitions for future CV 
and renal outcomes trials, and characterize disease progression over time.

If this sounds like you, apply now!

Essential Education and Experience:

  *   A PhD and/or a recent Postdoctoral fellowship in a quantitative 
discipline (pharmacometrics, engineering, pharmacology, computational biology, 
applied math, or related)
  *   Success demonstrated by scientific publications and conference 
presentations
  *   Interest in applying quantitative tools to solve clinically-meaningful 
problems
Desirable Qualifications:

  *   Working knowledge of biology and physiology
  *   Experience working with clinical data
Skills and Capabilities:

  *   Proficiency and hands-on experience with data analysis, machine learning, 
and/or computational modelling in R or similar software
  *   Ability to communicate technical material to a broad audience
  *   Proven track record of effectively working independently, as well as 
within a team, to achieve results

This is a 2-year program, which will be based in Gaithersburg, MD or Waltham 
(Boston), MA with a competitive salary/benefits on offer

About AstraZeneca
AstraZeneca is a global, innovation-driven biopharmaceutical business that 
focuses on the discovery, development and commercialization of prescription 
medicines for some of the world's most serious diseases. But we're more than 
one of the world's leading pharmaceutical companies. At AstraZeneca, we're 
proud to have a unique workplace culture that inspires innovation and 
collaboration. Here, employees are empowered to express diverse perspectives - 
and are made to feel valued, energized and rewarded for their ideas and 
creativity.


Chris Penland, PhD
Clinical Pharmacology & Quantitative Pharmacology
__________________________________________
AstraZeneca
R&D | Clinical Pharmacology & Safety Sciences
35 Gatehouse Dr, Waltham, MA USA 02451
T: +1 781 839 4618  M: +1 617 275 3769
chris.penl...@astrazeneca.com<mailto:chris.penl...@astrazeneca.com>

Please consider the environment before printing this e-mail





________________________________

Confidentiality Notice: This message is private and may contain confidential 
and proprietary information. If you have received this message in error, please 
notify us and remove it from your system and note that you must not copy, 
distribute or take any action in reliance on it. Any unauthorized use or 
disclosure of the contents of this message is not permitted and may be unlawful.

Reply via email to